Grant: Engage Grants Program
University of Windsor
$25,000.00
Stem cells as a bio-resource for cosmeceutical product development
EF 2015-16
Résumé
BioCella Medical Concept Solutions Inc. is a cosmeceutical company which designs and formulates skin care products based on medical principles. BioCella wishes to develop an innovative anti-aging product which would employ human adult stem cell-derived growth factors, unlike cosmetic products which are presently in the market place and use plant-derived stem cell extracts with no to minimal efficacy. The company does not have the technical knowledge to solve the issue of extracting such peptides or growth factors; therefore, is requesting the expertise of Dr. Crawford to provide a robust protocol to isolate human adult stem cells and purification of the secretory factors which will be incorporated into cosmeceutical products. The company also wishes for scientific validation of the benefits of these active molecules on skin rejuvenation using cell-based
assays. By combining the latest discoveries in the fields of stem cell biology and skin care technology, BioCella hopes to formulate the most effective and scientifically tested anti-aging products. Although the finished products would be applicable in the management of UV damaged photoaging and personalized skin care, the results from this study may eventually lead to new therapies for skin wound-healing and regeneration.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
491569-2015
Name nom
Crawford, Michael
Department département
Biological Sciences
Organization id
37
Institution établissement
University of Windsor
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
1
Nb partie
1
Application title
Stem cells as a bio-resource for cosmeceutical product development
Keyword
NSERC
Application summary
BioCella Medical Concept Solutions Inc. is a cosmeceutical company which designs and formulates skin care products based on medical principles. BioCella wishes to develop an innovative anti-aging product which would employ human adult stem cell-derived growth factors, unlike cosmetic products which are presently in the market place and use plant-derived stem cell extracts with no to minimal efficacy. The company does not have the technical knowledge to solve the issue of extracting such peptides or growth factors; therefore, is requesting the expertise of Dr. Crawford to provide a robust protocol to isolate human adult stem cells and purification of the secretory factors which will be incorporated into cosmeceutical products. The company also wishes for scientific validation of the benefits of these active molecules on skin rejuvenation using cell-based
assays. By combining the latest discoveries in the fields of stem cell biology and skin care technology, BioCella hopes to formulate the most effective and scientifically tested anti-aging products. Although the finished products would be applicable in the management of UV damaged photoaging and personalized skin care, the results from this study may eventually lead to new therapies for skin wound-healing and regeneration.